Replies to post #149828 on Biotech Values

[DewDiligence]

The LLY/B-I JV also has a SGLT-2 inhibitor called Empagliflozin; this is what they had to say about it at EASD:

http://finance.yahoo.com/news/pooled-analysis-demonstrated-reductions-systolic-095900540.html

[north40000]

Is a subjective survey measure of anxiety and fear really a measurable endpoint? New one on me--I have been taking measured insulin dose for 55 years and do not remember consciously thinking fear or anxiety when dosing.

...patients treated with LY2605541 reported a statistically significant reduction in the anxiety and fear associated with experiencing a hypoglycaemic event based upon the Adult Low Blood Sugar Survey (ALBSS).